Boston Financial & Equity closed a $1 million lease line for an emerging growth company based in Cambridge, MA. The company is an integrated drug discovery and development company focused on the immune system. The company has attracted more than $50 million in series A funding to build a fully integrated biopharmaceutical company from the ground up.
Although the company has $20 million in cash, it uses $2 million a month. When it has FDA clearance, it expects another round of funding. Its first takedown is for a hardware/software enterprise platform for R&D, and, moving forward, for needed lab equipment to equip its new lab space.
Like this story? Begin each business day with news you need to know! Click here to register now for our FREE Daily E-News Broadcast and start YOUR day informed!